Performing Shares of the Day: Xilinx Inc. (NASDAQ:XLNX), Cidara Therapeutics, Inc. (NASDAQ:CDTX)

Xilinx Inc. (NASDAQ:XLNX)

The shares of Xilinx Inc. (NASDAQ:XLNX) started off the last trading session with the price of $75.77 while closing the day with the price of $75. The shares of Xilinx Inc. (NASDAQ:XLNX) Fell -1.35% with the Loss of -0.77 points.

The shares of Xilinx Inc. (NASDAQ:XLNX) traded with the day volume of 2.45 Million shares whereas its average trading volume is 2.64 Million.

While analyzing the past performance of the stock we can see that the shares of Xilinx Inc. (NASDAQ:XLNX) Loss -2.69% in the last week while rising 11.57% in the last month. Past quarter performance shows the green light with 10.18%. The semi-annual and annual performance shows 9.76% and 24.83% respectively.

Some critical values of the shares of Xilinx Inc. (NASDAQ:XLNX) to be discussed here are: the beta which shows the value at 1.11 while Average True Range of Xilinx Inc. (NASDAQ:XLNX) demonstrate the value at 1.83. The weekly and monthly volatility of the shares of Xilinx Inc. (NASDAQ:XLNX) are indicated at 2.24% and 2.24%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 56.49.

While studying the financial position of the shares of Xilinx Inc. (NASDAQ:XLNX), we can see that the Market capitalization of the company is at 19.06 Billion. The shares outstanding for the company is 254.14 Million and the shares float stands at 254.11 Million. The income of the company stand at 658.6 Million while the sales stand at 2.48 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.51, Price to Earnings or P/E is at 29.87, Price to Sales P/S show the value of 7.7, the Return on Asset ROA stood at 0.1 and the Return on Equity ROE depicted at 0.202 while Return on Investment ROI is at 0.159.


Cidara Therapeutics, Inc. (NASDAQ:CDTX)

Cidara Therapeutics, Inc. (NASDAQ:CDTX) started its previous trading session at $6.85 and closed at $6 showing a Fell of -24.05 Percent.

The Company traded with an average Volume of 111.69 Million whereas, its Day Volume stood at 2.45 Million.

Looking at the performance of the stock, Cidara Therapeutics, Inc. (NASDAQ:CDTX) Loss -25.47% in the last week in its shares price and -11.76% in the last month. Quarterly performance shows a red of -15.49 Percent while Semi-Annual and Annual performances shows a -14.29 and -16.08 percent respectively.

Beta for Cidara Therapeutics, Inc. (NASDAQ:CDTX) stands at 0 while the ATR (average true range) is at 0.57. The Stock’s Weekly and Monthly Volatility is 7.51% and 6.91% respectively showing a RSI value of 34.12.

While studying the financial position of the shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX), we can see that the Market capitalization of the company is at 125.22 Million. The shares outstanding for the company is 20.87 Million and the shares float stands at 19.12 Million.

The Company generated an income of -55700000 and the sales of 0 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-3.2 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 0 respectively.

The Return on Assets stands at -0.696, ROE shows a value of -0.9 and ROI for Cidara Therapeutics, Inc. (NASDAQ:CDTX) is 0 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment